相关实验视频

Updated: Jul 16, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

泰国C型肝炎的简化测试治疗策略:Phetchabun模型

Rujipat Wasitthankasem¹, Nasamon Wanlapakorn², Napaporn Pimsing³

¹National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.

The Journal of infectious diseases

|September 13, 2023

概括

简化的型肝炎病毒 (HCV) 测试治疗策略对泰国来说是有前途的.

科学领域:

肝病学肝病学是一种肝病学.
传染性疾病传染性疾病
公共卫生公共卫生

背景情况:

在泰国,由于复杂的诊断和普遍医疗覆盖标准,消除C型肝炎病毒 (HCV) 面临挑战.
在Phetchabun省存在很高的HCV负担,需要有效的查和治疗策略.

研究的目的:

评估一种简化的HCV测试治疗策略,将快速诊断测试 (RDT) 和核酸测试结合起来.
评估这一策略对全民HCV查和加快治疗的可行性.

主要方法:

这项研究实施了初始查的点照顾RDT.
积极的RDT结果随后进行了定性核酸测试以确认.

主要成果:

简化试验治疗策略显示了在泰国国家一级实施的潜力.
发现的挑战包括严格的全民健康覆盖标准,政策修订,公众意识低,政策优先级等.

结论:

评估的HCV测试治疗策略提供了一种有希望的方法来简化诊断和治疗.
解决实施障碍对于推进泰国消除肝炎的努力至关重要.

关键词:

在HCV病毒感染的过程中,在HCVRNA测试中,检测出HCVRNA.淘汰淘汰消除淘汰快速诊断测试是一种快速诊断测试.试验到处理的试验到处理.

更多相关视频

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

相关概念视频

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...